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Abstract
Several recent cohort studies have found an association between smoking and
breast cancer, but the association between lifetime smoking exposure and breast
cancer mortality is less well described. We examined whether smoking before
breast cancer diagnosis is a predictor of breast cancer mortality in a large
cohort with more than 4.1 million years of follow-up, with a special focus on
women who initiated smoking before first childbirth. Information on smoking
status was collected before breast cancer diagnosis and used to estimate hazard
ratios (HRs) and corresponding 95% confidence intervals (CIs) of breast cancer
mortality in a cohort of 302,865 Norwegian women with 1106 breast cancer
deaths. Women were enrolled between 1974 and 2003 and followed up through
linkages to national registries until 31 December 2007. We found that breast
cancer mortality was slightly but significantly increased for current (HR = 1.15,
95% CI 1.01–1.32) and ever (HR = 1.15, 95% CI 1.02–1.30) smokers as com-
pared to never smokers. No statistically significantly increased mortality was
found for women who initiated smoking before first childbirth, and no dose-
response association was revealed for any of the different measures of smoking
exposure. A large proportion of heavy smokers may have died from other
causes than breast cancer during follow-up, possibly diluting our results. This
study found that lifetime smoking exposure had a significantly increased risk of
breast cancer mortality compared with never smokers.
Introduction
In the past 30 years in Norway, breast cancer incidence
has almost doubled while mortality has been stable, or
decreased, in the same period [1–4]. In 2011, 3094
women were diagnosed with breast cancer in Norway,
and 605 women died from the disease the same year [3].
This difference in incidence and mortality reflects the
good prognosis of breast cancer, especially when diag-
nosed at an early stage. Nevertheless, breast cancer
remains the leading cause of cancer death among women
worldwide [5].
The International Agency for Research on Cancer
recently classified cigarette smoking as possibly carcino-
genic to the human breast [6], but the relationship
between smoking and breast cancer is still controversial
[7–10]. Several large prospective cohort studies have
found that smoking may cause breast cancer particularly
in women who smoke for a long time, in those who
smoke many cigarettes per day, and in those who initi-
ated smoking before the first childbirth [11–20]. The
association between lifetime smoking exposure and breast
cancer mortality is uncertain and not well described in
the literature [21–24]. Most previous studies have assessed
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smoking status at breast cancer diagnosis, finding an
increased risk among current but not among former
smokers [25–32], possibly underestimating the effect of
lifetime smoking exposure among former smokers [23,
24].
The proportion of women who smoke daily in Norway
increased from 23% in 1954 to 37% in 1970, before stabi-
lizing at around 32% for the rest of the century [33]. This
high percentage, together with an increased proportion of
women smoking before the first childbirth in younger
birth cohorts [19], represents a suitable setting for study-
ing the association between lifetime smoking exposure
and breast cancer mortality in this large pooled cohort.
Cancer mortality is a function of incidence influenced
by exposure to lifetime risk factors, inherited factors and
survival after diagnosis [34]. Exposure to risk factors in
the period before breast cancer diagnosis is likely to influ-
ence the development of the disease [35], and modifiable
risk factors from this period are important to identify. In
this study, we used information collected before breast
cancer diagnosis to examine the potential importance of
smoking before diagnosis as a predictor of breast cancer
mortality. Smoking in the time period from menarche to
first childbirth has emerged as a risk factor for breast can-
cer in many epidemiological studies [7, 8, 14, 16–19, 36],
and animal studies have confirmed that mammary cells
are more vulnerable to chemical carcinogens in this time
period [37]. Our particular interest was whether the
increased breast cancer risk for female smokers who initi-
ate smoking before first childbirth increases the risk of
dying from breast cancer later in life [19].
Materials and Methods
Study population
The study population comprised Norwegian women
recruited into three prospective cohort studies conducted
by the National Health Screening Service (now the Nor-
wegian Institute of Public Health): the Norwegian Coun-
ties Study (1974–1988), the 40 Years Study (1985–1999)
and the Cohort of Norway (CONOR) Study (1994–2003).
Selection of participants in these studies was usually based
on year of birth and residence (municipality or county).
A total of 330,342 women were eligible before exclusion,
and if any women participated in more than one study
only the first record was used. All women with a cancer
diagnosis prior to start of follow-up (n = 7138), women
without information on smoking status (n = 2808), edu-
cation level (n = 6913), body mass index (BMI,
n = 2478), and physical activity (n = 4207) were excluded
from the present analysis, leaving 302,865 women in the
analytical cohort.
The response rate in the three studies varied from 56%
to 88% [38]. All participants recruited as from 1994 gave
written informed consent to participate in the studies;
before 1994 returning the completed questionnaire was
considered sufficient as acceptance to participate in the
studies. This study was approved by the Regional Com-
mittee for Medical Research Ethics South-East, Norway.
The design and protocol of the three studies were simi-
lar, although some modifications regarding smoking, level
of physical activity and other lifestyle factors were made
in the questionnaires at different time periods [39–41].
All studies had a baseline questionnaire which included
detailed assessments of smoking habits, level of physical
activity, and other lifestyle factors, but not hormone
replacement use. In addition, questions on alcohol con-
sumption were only included from 1994 onwards. The
wording of the questionnaires was standardized when the
CONOR collaboration was initiated in 1994 [41].
Exposure information
After receiving specified variables from the primary data
of each study, we created a standardized database for the
pooled analysis based on the CONOR database. The
smoking questions were similar, but not identical, across
all surveys. Based on their responses at study enrolment,
participants were classified as never, former, or current
smokers, which remained the classification throughout
the follow-up period. Current and former smokers were
considered ever smokers, and were further classified by
age at smoking initiation, smoking duration in years,
average number of cigarettes smoked per day and number
of pack-years (i.e., number of cigarettes smoked per day,
divided by 20, multiplied by the smoking duration in
years). Only the CONOR Study had a specific question
related to age at smoking initiation. In the other two
studies we calculated this variable for both current smok-
ers (age at enrolment minus smoking duration in years)
and former smokers (age at quitting smoking minus
smoking duration in years). For parous women, the vari-
able “smoking duration before first childbirth” was calcu-
lated as age at first childbirth minus age at smoking
initiation. All participants who were neither current nor
former smokers were classified as never smokers, and
never smokers constitute the reference group throughout
this paper, unless otherwise noted.
Participants were categorized into three groups based
on their level of physical activity at enrolment: sedentary
(reading, watching television, sedentary activity, walking
or bicycling, <4 h per week), moderate (walking, bicy-
cling, and/or similar activities ≥4 h per week), and heavy
(light sports or heavy gardening ≥4 h per week, heavy
exercise or daily competitive sports). The most recent
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information regarding duration of education obtained
from Statistics Norway was used to assign participants to
one of three categories according to duration of educa-
tion: <10, 10–12, ≥13 years. Information on number of
children and age at first childbirth was also obtained
through linkages to Statistics Norway. As questions on
alcohol consumption were only included from 1994
onwards, information on alcohol consumption was miss-
ing in 62% of the women in the analytical cohort.
Follow-up and endpoints
We followed all participants through linkages with the
Cancer Registry of Norway, the Norwegian Cause of Death
Registry, and the Central Population Register using the
unique 11-digit personal identification number to identify
all cancer cases, deaths and emigrations. Information
about tumor stage at diagnosis, or treatment, was not con-
sidered in our analysis. These national registries are accu-
rate and may be regarded as virtually complete [42]. The
start of follow-up was set to January 1 the year following
completion of the baseline questionnaire. The Interna-
tional Classification of Diseases (ICD-9/ICD-10) codes
were used to identify breast cancer as the underlying cause
of death in the registries. To correct for errors and mis-
taken conclusions drawn by the physician, rules from the
World Health Organization are used to ensure correct
classification on the basis of the death certificate [43, 44].
Statistical analysis
We used Cox proportional hazard models (with age as
the underlying time scale) to estimate the multivariate-
adjusted hazard ratios (HRs) with 95% confidence inter-
vals (CIs) of breast cancer mortality associated with dif-
ferent measures of smoking exposure (age at smoking
initiation [≤19, 20–24 and ≥25 years], smoking duration
[≤10, 11–20, and ≥21 years], number of cigarettes smoked
per day [≤5, 6–10, ≥11 cigarettes], number of pack-years
[≤5, 6–10, ≥11 pack-years], and for parous women smok-
ing duration in relation to first childbirth [more than
1 year after first childbirth, around [i.e., 1 year before to
1 year after], >1–6 years before, ≥7 years before first
childbirth]). Entry time in the statistical model was
defined as age at enrolment, and exit time as age at death,
emigration or the end of follow-up (31 December 2007),
whichever occurred first.
The covariates included in the final models, decided a
priori, were age at enrolment (continuous variable), dura-
tion of education (<10, 10–12, ≥13 years), number of
children (0, 1–2, 3–4, ≥5), age at first childbirth (<20, 20–
24, 25–29, ≥30 years), BMI (<25, 25–29, ≥30 kg/m2) and
level of physical activity (sedentary, moderate, heavy). We
analyzed the age- and multivariate-adjusted HRs with
95% CIs for breast cancer mortality according to the
selected covariates included in the multivariate analysis.
The multivariate analysis in Tables 2 and 3 were strati-
fied by the three studies. Further, we estimated the possi-
ble impact of differences in birth cohorts, and stratified
the full cohort by birth year (≤1950>) for the multivariate
analysis in Tables 2 and 3 (data not shown). Alcohol con-
sumption was categorized as less than weekly (including
teetotallers), weekly and more than weekly, and was
included in the multivariate model in a subanalysis as an
adjusting variable. We did tests for linear trends across
the different levels of smoking exposures, including the
reference category (Table 2), excluding never smokers
(Table 3). The results were considered significant if the P
value was <0.05, or if the CIs were outside 1.00. All P val-
ues are two sided. The analyses were done in STATA ver-
sion 12.0 (StataCorp, College Station, TX), and SAS
version 9.4 (SAS Institute Inc., Cary, NC).
Results
At study enrolment, the mean age was 44 years and 59%
of the 302,865 Norwegian women were ever smokers.
During 14 years of median follow-up, we confirmed 1106
breast cancer deaths and 14,446 deaths by all other causes.
Mean age at breast cancer death was 61 years in the
Counties Study, 54 years in the 40 Years Study and
66 years in the CONOR Study (Table 1).
Table 2 shows that for women overall, significant dose-
response associations with breast cancer mortality were
observed for parity (inversely related: Ptrend < 0.01), and
were positively related with age at first childbirth
(Ptrend < 0.01) and with BMI (Ptrend = 0.02). Information
on alcohol consumption was only available for 36.9% of
the women, and showed a nonsignificant 22% increased
risk of breast cancer mortality for those drinking > weekly
(HR = 1.22, 95% CI 0.73–2.03).
Table 3 shows that the overall results for former
(HR = 1.14, CI 0.97–1.34) and current (HR = 1.15, 95%
CI 1.01–1.32) smokers had similar increased risks for
breast cancer mortality in the multivariate analysis com-
pared with never smokers. For ever smokers a signifi-
cantly increased risk was found among women who
initiated smoking at ≥25 years of age (HR = 1.31, 95%
CI 1.08–1.59), among those smoking 11–20 years of dura-
tion (HR = 1.20, 95% CI 1.03–1.40), and among those
smoking ≥11 cigarettes per day (HR = 1.25, 95% CI
1.06–1.46). Parous women who initiated smoking 7 years
or more before first childbirth had a 24% (HR = 1.24,
95% CI 0.98–1.58) nonsignificantly increased breast can-
cer mortality compared to never smokers. The overall
results revealed no dose-response associations for any of
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the different measures of smoking exposure (age at smok-
ing initiation, smoking duration, number of cigarettes
smoked per day, number of pack-years, and smoking
duration before first childbirth, all P for trends ≥0.05)
and breast cancer mortality. One significant dose-response
association with breast cancer mortality was observed in
the Counties Study for number of cigarettes smoked per
day (Ptrend < 0.01), but no other consistent pattern was
revealed for the trend test when analyzed by study. For
smoking duration, we found a reduction in risk increase
for smoking 11–20 years from 20% (HR = 1.20, 95% CI
1.03–1.40) to nonsignificant 6% (HR = 1.06, 95% CI
0.89–1.27) for smoking ≥21 years. A subanalysis for high
number of pack-years as a measure of high lifetime smok-
ing exposure showed a nonsignificant increase in breast
cancer mortality of only 3% (HR = 1.03, 95% CI 0.79–
1.34) for ≥21 pack-years (66 cases).
We also did a stratified analysis by birth cohorts
(≤1950>), including 149,270 and 878 breast cancer deaths
for those born in and before 1950, and 153,595 women
and 228 breast cancer deaths in those born after 1950.
We found a 5% difference in breast cancer mortality risk
for ever smokers as compared with never smokers, for the
oldest birth cohort (HR = 1.15, 95% CI 1.00–1.32) and
the corresponding figure for those born after 1950
(HR = 1.20, 95% CI 0.90–1.59). The test for heterogene-
ity revealed no significant difference (PWald = 0.80). Com-
paring the highest number of pack-years (≥11 pack-years)
between these birth cohorts showed a 3% risk difference
(HR = 1.20, 95% CI 1.00–1.43) and (HR = 1.17, 95% CI
0.82–1.66), respectively.
Stratification by birth cohort (≤1950>) showed a 15%
difference in breast cancer mortality for ever smokers as
compared with never smokers, for those born in 1950 or
before (HR = 1.15, 95% CI 1.00–1.32) and the corre-
sponding figure for those born after 1950 (HR = 1.30,
95% CI 0.93–1.80). The test for heterogeneity revealed no
significant difference (PWald = 0.52). Stratification for the
other exposure variables (age at smoking initiation, smok-
ing duration, number of cigarettes smoked per day, num-
ber of pack-years and smoking duration before first
childbirth) by birth cohort (≤1950>) all showed nonsig-
nificant results (data not shown).
We included alcohol consumption as a covariate in the
multivariate model after excluding women without alco-
hol information, restricting the sample size to 114,804
women. All the results became statistically nonsignificant.
For ever smokers as compared with never smokers, the
estimate for breast cancer mortality increased to 20%
(HR = 1.20, 95% CI 0.82–1.75). For former smokers the
Table 1. Selected characteristics of the analytical cohort, stratified by studies, among 302,865 Norwegian women (1974–2003).
Characteristics Counties Study 40 Years Study CONOR Study All
Study period 1974–1987 1985–1999 1994–2003 1974–2003
Person years of follow-up 1,075,997 2,577,627 510,690 4,164,314
Participants 41,573 199,729 61,563 302,865
Age1, mean, SD 40  7 43  5 48  15 44  9
Year of birth, median, (range) 1939 (1932–1944) 1951 (1948–1954) 1955 (1941–1960) 1951 (1946–1955)
Age at breast cancer diagnosis, mean, SD 58  9 52  7 59  13 54  9
Year of breast cancer diagnosis, median, (range) 1998 (1991–2003) 2002 (1998–2005) 2004 (2001–2005) 2002 (1997–2005)
Age at breast cancer death, mean, SD 61  9 54  8 66  16 58  10
Number of breast cancer deaths 405 624 77 1106
Ever daily smokers1 among breast cancer deaths (%) 54 62 53 58
Age at death, all causes2, mean, SD 65  9 60  13 78  13 66  14
Number of deaths, all causes2 5401 6471 3680 15,552
Ever daily smokers1 among dead from all causes2 (%) 66 67 46 61
Follow-up years, median 30 13 9 14
≥13 years of education, (%) 12 22 21 21
Number of children, mean, SD 2  2 2  1 2  1 2  1
Body mass index1, mean, (kg/m²) 24 24 25 25
Level of physical activity, heavy1,3 (%) 11 21 28 21
Smoking status1
Never daily smokers (%) 46 39 44 41
Ever daily smokers4 (%) 54 61 56 59
A former smoker has been a daily smoker previously. SD standard deviation, Range interquartile range.
1At enrollment.
2Deaths by all causes includes deaths by breast cancer.
3Heavy physical activity is defined as light sports or heavy gardening ≥4 h per week, heavy exercise or daily competitive sports.
4Ever smoker: current and former smoker.
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corresponding figure increased to 26% (HR = 1.26, 95%
CI 0.82–1.96), and for current smokers it decreased to
13% (HR = 1.13, 95% CI 0.73–1.76). A Wald’s test for
heterogeneity between the subpopulation with alcohol
information and the full analytical cohort yielded nonsig-
nificant results for ever (PWald = 0.84), current
(PWald = 0.93) and former smokers (PWald = 0.67).
Discussion
Overall, we observed a slight increase in breast cancer
mortality among ever smokers compared to never
smokers, with similar results when the analyses were strat-
ified by the three studies, and by birth cohort. No statisti-
cally significantly increased mortality was found for
women who initiated smoking before first childbirth, and
no dose-response association was revealed for any of the
different measures of smoking exposure (age at smoking
initiation, smoking duration, number of cigarettes
smoked per day, number of pack-years, or smoking dura-
tion before first childbirth).
Our finding of an increased smoking-related risk of
breast cancer mortality, but without a dose-response asso-
ciation between the exposure and outcome variables, is
probably a result of competing risks of mortality, as heavy
and long-term smokers could have died from other
Table 2. Mulitvariate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer mortality1, stratified by studies, according
to selected covariates.
Counties Study BC cases 40 Years Study BC cases CONOR Study BC cases All studies BC cases
Duration of education (years)
<10 Ref. 176 Ref. 168 Ref. 26 Ref. 370
10–12 1.12 (0.90–1.38) 178 0.91 (0.75–1.11) 330 1.18 (0.69–2.28) 37 1.00 (0.86–1.14) 545
≥13 1.40 (1.02–1.93) 51 0.96 (0.75–1.23) 126 1.32 (0.64–2.71) 14 1.09 (0.91–1.31) 191
Ptrend 0.05 0.71 0.43 0.44
Number of children
0 Ref. 71 Ref. 79 Ref. 10 Ref. 160
1–2 0.55 (0.33–0.91) 177 0.50 (0.34–0.74) 356 0.44 (0.13–1.55) 40 0.50 (0.37–0.67) 573
3–4 0.41 (0.24–0.68) 135 0.40 (0.26–0.60) 179 0.37 (0.10–1.34) 25 0.38 (0.28–0.52) 339
≥5 0.26 (0.14–0.50) 22 0.29 (0.14–0.59) 10 0.19 (0.04–1.17) 2 0.25 (0.16–0.39) 34
Ptrend <0.01 <0.01 0.09 <0.01
Age at first childbirth2 (year)
<20 Ref. 24 Ref. 61 Ref. 6 Ref. 91
20–24 1.29 (0.84–1.99) 153 1.15 (0.86–1.53) 238 0.84 (0.34–2.12) 21 1.17 (0.93–1.47) 412
25–29 1.40 (0.88–2.22) 103 1.44 (1.05–1.96) 160 0.94 (0.35–2.51) 17 1.40 (1.09–1.79) 280
≥30 1.61 (0.97–2.70) 125 1.84 (1.29–2.63) 165 2.09 (0.75–5.81) 33 1.82 (1.40–2.40) 323
Ptrend 0.07 <0.01 0.04 <0.01
Body mass index3 (kg/m²)
<25 Ref. 246 Ref. 389 Ref. 24 Ref. 659
25–29 1.07 (0.86–1.35) 146 1.11 (0.93–1.33) 245 1.73 (1.01–2.96) 38 1.12 (0.98–1.29) 429
≥30 1.32 (0.96–1.81) 63 1.07 (0.81–1.42) 76 2.17 (1.17–4.02) 25 1.22 (1.01–1.49) 164
Ptrend 0.02 0.33 0.01 0.02
Physical activity3
Sedentary Ref. 87 Ref. 130 Ref. 40 Ref. 257
Moderate 1.01 (0.79–1.28) 277 0.93 (0.76–1.13) 416 0.80 (0.48–1.33) 25 1.00 (0.86–1.15) 718
Heavy 0.95 (0.66–1.39) 41 0.69 (0.52–0.92) 78 0.74 (0.38–1.47) 12 0.78 (0.63–0.97) 131
Ptrend 0.87 0.02 0.32 0.06
Alcohol consumption3,4
<Weekly5 NA Ref. 42 Ref. 47 Ref. 89
Weekly NA 1.78 (0.98–3.22) 15 0.42 (0.14–1.18) 4 1.05 (0.63–1.74) 19
>Weekly NA 1.34 (0.72–2.50) 14 1.06 (0.41–2.77) 5 1.22 (0.73–2.03) 19
Ptrend 0.18 0.49 0.46
Adjusted for age, education level, number of children, age at first childbirth, BMI, age at enrollment and physical activity.
Trend tests between the three or four levels of categories, including the reference category.
1Deaths by breast cancer (n = 302,865 with 1106 cases).
2Nulliparous (n = 36,523) not included.
3At enrollment.
4Only women with alcohol information included (n = 114,804).
5Including teetotalers.
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smoking-related diseases [45, 46]. Also, the excellent sur-
vival of breast cancer patients in Norway could make this
association more difficult to study [3].
The smoking pattern in Norway [47], as in other coun-
tries [48], has changed considerably in recent generations,
with a high smoking prevalence in the birth cohorts dur-
ing and just after World War II. Our previous study
showed an increased breast cancer incidence among ever
smokers as compared to never smokers, particularly
among those initiating smoking before the first childbirth,
as for other exposures [19]. These increases in risk were
not replicated for breast cancer mortality in the present
analysis due to lack of significant dose-response results.
Most previous studies examining the association
between smoking and death from breast cancer have
assessed smoking status at breast cancer diagnosis without
consideration of lifetime smoking exposure [25–32], dis-
regarding the fact that the hazards of smoking are often
Table 3. Mulitvariate adjusted hazards ratios (HRs) and 95% confidence intervals (CIs) for breast cancer mortality1, stratified by studies, with
never smokers as the reference group.
Smoking exposures
Person
Years (ALL)
Cases
(ALL) Counties Study 40 Years Study CONOR Study All studies
Smoking status
Never 1,733,948 459 Ref.
Ever 2,430,366 647 1.18, (0.97–1.44) 1.15 (0.97–1.36) 1.26 (0.78–2.03) 1.15–(1.02–1.30)
Former 819,115 216 1.06 (0.79–1.44) 1.17 (0.95–1.45) 1.39 (0.81–2.38) 1.14 (0.97–1.34)
Current 1,611,251 431 1.23 (0.99–1.52) 1.13 (0.94–1.36) 1.11 (0.60–2.04) 1.15 (1.01–1.32)
Cases 405 624 77 1106
Ever smokers
Age at smoking initiation (years)
≥25 355,209 137 1.33 (1.00–1.77) 1.26 (0.95–1.67) 1.28 (0.61–2.69) 1.31 (1.08–1.59)
20–24 585,167 149 1.03 (0.74–1.43) 1.10 (0.86–1.40) 0.85 (0.37–1.93) 1.04 (0.86–1.26)
≤19 921,599 182 1.36 (0.98–1.88) 1.00 (0.78–1.27) 1.37 (0.75–2.50) 1.05 (0.87–1.25)
Sum 468 Ptrend 0.082 Ptrend 0.11 Ptrend 0.66 Ptrend 0.052
Smoking duration2 (years)
≤10 702,018 178 1.24 (0.94–1.63) 1.08 (0.85–1.38) 1.40 (0.68–2.91) 1.13 (0.95–1.35)
11–20 1,008,418 291 1.17 (0.91–1.49) 1.23 (1.01–1.51) 0.91 (0.41–2.02) 1.20 (1.03–1.40)
≥21 703,524 178 1.12 (0.79–1.59) 1.05 (0.83–1.32) 1.27 (0.71–2.26) 1.06 (0.89–1.27)
Sum 647 Ptrend 0.23 Ptrend 0.27 Ptrend 0.53 Ptrend 0.43
Number of cigarettes per day
≤5 438,860 126 1.00 (0.71–1.39) 1.37 (1.06–1.78) 1.17 (0.57–2.38) 1.18 (0.97–1.43)
6–10 1,071,909 263 1.04 (0.81–1.34) 1.08 (0.88–1.33) 1.17 (0.63–2.16) 1.06 (0.91–1.23)
11–15 553,968 161 1.65 (1.22–2.24) 1.13 (0.89–1.45) 0.70 (0.24–2.00) 1.25 (1.04–1.51)
≥16 350,559 97 1.53 (1.00–2.33) 1.08 (0.81–1.43) 2.53 (1.18–5.43) 1.24 (0.99–1.55)
Sum 647 Ptrend <0.01 Ptrend 0.50 Ptrend 0.27 Ptrend 0.26
Number of pack-years3
≤5 811,590 211 1.09 (0.84–1.41) 1.15 (0.92–1.44) 1.52 (0.82–2.85) 1.12 (0.95–1.32)
6–10 650,196 183 1.12 (0.84–1.48) 1.18 (0.93–1.50) 0.84 (0.35–2.04) 1.14 (0.95–1.36)
11–15 474,227 132 1.45 (1.04–2.01) 1.13 (0.80–1.46) 1.08 (0.44–2.63) 1.22 (1.00–1.49)
≥16 468,639 121 1.35 (0.89–2.06) 1.07 (0.83–1.39) 1.30 (0.65–2.62) 1.13 (0.92–1.39)
Sum 647 Ptrend 0.13 Ptrend 0.94 Ptrend 0.78 Ptrend 0.61
Smoking duration before first childbirth among parous women (years)
After first childbirth (>1 year) 362,485 104 1.15 (0.83–1.58) 0.94 (0.69–1.29) 0.84 (0.29–2.38) 1.03 (0.83–1.28)
Around childbirth4 274265 62 1.11 (0.71–1.72) 0.84 (0.59–1.21) 1.58 (0.55–4.56) 0.94 (0.72–1.24)
>1–6 years before 629,381 157 1.32 (0.95–1.84) 1.22 (0.95–1.56) 1.00 (0.49–2.03) 1.17 (0.97–1.41)
≥7 years before 388,480 89 1.56 (0.99–2.76) 1.24 (0.91–1.70) 1.27 (0.64–2.55) 1.24 (0.98–1.58)
Sum 412 Ptrend
5 0.73 Ptrend
5 0.60 Ptrend
5 0.68 Ptrend
5 0.47
Adjusted for age, education level, number of children, age at first childbirth, BMI, age during enrollment and physical activity.
Trend tests between the levels of smoking categories excluding never smokers, except otherwice noted.
1For breast cancer deaths (n = 302,865 with 1106 cases).
2Total number of years smoked.
3Pack years: Number of cigarettes smoked per day multiplied by number of years smoked. One pack has 20 cigarettes.
41 year before to 1 year after first childbirth.
5Trend tests between three levels of smoking categories (around, >1–6, ≥7), excluding never smokers and smoking after first childbirth.
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accumulated with exposure [6], and that the period
before, and not after, breast cancer diagnosis is essential
in respect to carcinogenesis.
The report by Pirie et al. from the Million Women
Study found a 13% significantly increased risk for breast
cancer mortality associated with current smoking [22].
The study also performed sensitivity analyses for breast
cancer mortality among nondrinking women, reducing
the increase in risk from a significant 13% to a nonsignif-
icant 6%. Our sensitivity analyses, which included only
women with information on alcohol consumption
(n = 114,804), increased the risk for ever and former
smokers to 20% and 26%, respectively, and reduced the
risk for current smokers to 13%, as compared to the
main analysis. The tests for heterogeneity for smoking sta-
tus (ever, former, current), between the populations with
and without alcohol information revealed no significant
difference between the results for breast cancer mortality,
suggesting that alcohol consumption is of limited impor-
tance in this study. However, higher alcohol consumption
is a known risk factor for overall mortality [49], and may
have diluted our results by increasing competing risks
during follow-up. The paper from the US Cancer Preven-
tion Study II (1994) found a 26% statistically significantly
increased breast cancer mortality among current smokers,
and a nonsignificantly reduced mortality among former
smokers, as compared to never smokers [21]. In 2013, the
short report from the US Women’s Healthy Eating and
Living (WHEL) study including 2953 women and 245
breast cancer deaths during 7.3 years of follow-up found
a nonsignificantly increased breast cancer mortality
among current and former smokers reported at breast
cancer diagnosis. In the same study, the analysis was per-
formed by high-smoking exposure before breast cancer
diagnosis as a proxy for lifetime smoking exposure, find-
ing a significantly increased mortality risk of 54% for >20
pack-years [23]. Another study included three US cohorts
with 1059 breast cancer deaths and a mean exposure of
39 pack-years for current smokers. This study found 54%
significantly increased breast cancer mortality among for-
mer smokers with a very high lifetime smoking exposure
of more than 35 pack-years. No increase was found in
those with less smoking exposure [24]. Our analysis for
high smoking exposure showed that the increased breast
cancer mortality was reduced from 17% for those smok-
ing ≥11 pack-years to 3% for those smoking ≥21 pack-
years. Similarly, the risk was reduced from 20% for smok-
ing 11–20 years to 6% for smoking ≥21 years. A reduc-
tion in breast cancer mortality for women with the
highest smoking exposure may be explained by a greater
impact from competing risks in heavy smokers as com-
pared with less heavy smokers in this cohort, but con-
trasts with the recent study from the US showing
increased breast cancer mortality with very high exposure
[24]. Further, current smokers in this study had a mean
exposure of 13 pack-years, which is lower than the US
study, and may explain some of the conflicting results for
the highest smoking exposure categories. Taken together,
the previously conducted studies may suggest a causal
relationship between high- lifetime smoking exposure and
breast cancer mortality, but this study could not confirm
these results.
To our knowledge, no previous studies have examined
in detail the association with smoking before first child-
birth and breast cancer mortality, as presented in this
paper. We consider it a major strength that smoking
assessment in this study was conducted with smoking sta-
tus at enrolment, and not at breast cancer diagnosis, to
show the true risk between lifetime smoking exposure
and breast cancer death. Other strengths include its pro-
spective, nationwide population-based cohort design, the
large size and the complete follow-up through national
registries. Our analytical cohort included a large propor-
tion of young smoking females, many of whom initiated
smoking before first childbirth, which enabled us to study
this period in detail. Smoking histories were obtained at
enrolment and were not subject to recall bias. Other stud-
ies have found substantial differences in smoking status in
studies with long follow-up [22, 27]. Our data includes
smoking information at study enrolment only, and our
multivariate analysis by smoking status is between ever
and never smokers, leaving never smokers as the only cat-
egory that could possibly change status in the follow-up
period. This reduces the chance of misclassification bias
in the follow-up period. The smoking pattern in the Nor-
wegian population was stable in the follow-up period
1974–2007 with about 32% female current smokers [47].
Also, since very few Norwegians start to smoke after the
age of 30 and the mean age at enrolment in this study is
44 years, we do not expect changes in smoking status
among the never smokers to influence our risk estimates.
Our study also has important limitations: we were not
able to adjust for some covariates which may increase
breast cancer incidence, such as the use of hormone
replacement therapy, use of oral contraceptives, family
history of breast cancer, higher mammographic density,
higher age at menopause, lower age at menarche, weight
gain during adult life, or alcohol consumption [50, 51].
We used duration of education as a proxy for socioeco-
nomic status [52]. The Norwegian Breast Cancer Screen-
ing Programme and contemporary breast clinics were
established nationwide only 2 years before the end of the
follow-up of this study, and therefore we find it unlikely
that this has biased our results. Information about age at
smoking initiation was not reported in two of the three
studies and was calculated from other information
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reported in the questionnaires, which may have intro-
duced bias in any of the estimations of timing relative to
first childbirth. Using ever smokers in the analysis instead
of current and former smokers makes it impossible to
distinguish between current smoking, often used as a sur-
rogate for heavy smoking exposure, and former smoking,
often with a disparate smoking exposure history. Further-
more, around 10% of the female Norwegian population
has reported being occasional smokers during the last
four decades [47], but occasional and passive smokers
were probably included in never smokers in our study,
since we did not ask specific questions about these fac-
tors. Stage at diagnosis was not included as a confounder
in this study, but since our analysis is based on informa-
tion before diagnosis we do not consider this as a major
limitation. We lack complete data on other causes of
death, and we made no further attempts to assess other
competing risks of mortality. Finally, higher comorbidity
is a known adverse prognostic factor for death after breast
cancer diagnosis [53], and a large number of such com-
peting risks may have changed the associations in this
study towards the null, as women have died from other
causes than breast cancer during follow-up [45, 46].
Although still controversial [9], the rationale for an
increased breast cancer risk in women initiating smoking
before first childbirth is reported in many biological [37,
54] and epidemiological studies [7, 8, 14, 16–19, 36], but
the increased risk of dying from breast cancer has not
been previously assessed for this category. This study
found that lifetime smoking exposure had a significantly
increased risk of breast cancer mortality compared with
never smokers, but without clear dose-response associa-
tions. Further studies are needed, possibly in cohorts with
very high smoking exposure, in order to conclude an
association between lifetime smoking exposure and breast
cancer mortality.
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